Federal Register #FDA-2026-N-11623

FDA Rapid Response Surveys Information-Collection Extension

The FDA notice concerns voluntary public-health surveys, not a purchase of products or contracted services. - Government buyer: U.S. Department of Health and Human Services (HHS), Food and Drug Administration (FDA); no specific office is identified. - Requested activity: FDA seeks public comment on extending approval for its Rapid Response Surveys, which gather timely information to assess potential public-health problems and support safety and risk-management decisions. - Respondents: Participation is voluntary; potential respondents include manufacturers, distributors, sponsors, importers, consumers, healthcare professionals, hospitals, and other relevant facilities. - Estimated annual burden: 10,000 respondents and responses, one response per respondent, 30 minutes per response, and 5,000 total hours. - Products, vendors, and OEMs: No products, part numbers, vendors, or OEMs are specified. This is an information-collection notice, not a procurement opportunity.

Description

The FDA is seeking public comment on extending its information collection approval for rapid response surveys. The surveys gather information to help the Agency determine whether a problem affects public health and to make timely decisions about safety issues and risk-management solutions. Potential respondents include manufacturers, distributors, sponsors, importers, consumers, healthcare professionals, hospitals, and other facilities, as appropriate to each survey. Participation is voluntary, and the notice estimates 10,000 annual responses with a total burden of 5,000 hours.

View original listing